Macular Degeneration | MacularDegenerations.com

Category: Articles

  • It’s Not A Ghost, It’s Macular Degeneration

    If you or someone you know is struggling with vision challenges, particularly macular degeneration, it turns out that certain individuals may experience hallucinations that can be confusing, scary and unexplainable. It may make some people feel like they are going crazy when in reality it is a side effect of their disease. Sometimes symptoms of […]

  • Friends of Warminster Hospital Push for OCT Eye Scanner

    The Friends of Warminster Hospital intend to work toward getting a new scanner for the healthcare facility, reported This is Wiltshire on September 5. The scanner will be of benefit to patients who usually have to travel excessive distances to get treatment for their eye issues at other facilities. (MacularDegenerations.com) According to the article, the […]

  • Many AMD Patients in Australia Face Out-of-Pocket Expenses Hike for Treatment

    (http://www.MacularDegenerations.com) Many Australians with age-related macular degeneration (AMD) will soon face more out-of-pocket expenses for medications to treat their eye condition, according to The Sydney Morning Herald on September 2. The article, which looked at the case of 71-year-old Helen Ingleby, noted that the retired woman will face a substantial out-of-pock expense hike to $500 […]

  • Burnley Residents Enraged Over County’s Plan to Eliminate Electronic Timetables for Buses

    (www.MacularDegenerations.com) People living with age-related macular degeneration (AMD) are spitting mad over the fact that local government has apparently thumbed its nose at their request to restore the electronic timetables at the bus station in Burnley, UK, reported the Lancashire Telegraph. According to the article, Gordon Birtwistle, MP of Burnley, backed protesters affiliated with the […]

  • Alcohol Consumption Could Increase AMD Odds

    (MacularDegenerations.com) While there are studies suggesting that moderate use of alcohol has some medicinal value, those reports are only a drop in the bucket compared to the reports suggesting that imbibing can do more harm than good. A study backed by the American Health Assistance Foundation’s Macular Degeneration Research program looked at alcohol consumption records […]

  • Telescope Implant Surgery Helps Ohio Woman to Regain Sight Lost to AMD

    (http://www.MacularDegenerations.com) After a surgical procedure that almost seems like it was lifted out of the pages of a futuristic novel, 86-year-old Justine Wise has regained sight that had been lost due to age-related macular degeneration (AMD), reported the Post & Courier on August 21. On July 13, Wise, from Tiffin, Ohio, underwent a surgical procedure […]

  • Researchers Come Up with Prosthetic Device that Gives Blind Mice Close-to-Normal Vision

    Research into drugs and devices that could help people with age-related macular degeneration (AMD) to regain their lost eyesight is nothing new, but every now and then a significant development gives a new glimmer of hope. Such is the case in an article recently published the Examiner. According to the article, researchers at Cornell University, […]

  • US Seniors Have Better Eyesight than did Counterparts of the Previous Generation

    (www.MacularDegenerations.com) Seniors living in the United States of America aren’t out of the woods when it comes to eye diseases such as age-related macular degeneration (AMD), but a new study suggests that their eye health is better than was the eye heath of seniors a generation prior. According to an article from the Poughkeepsie Journal, […]

  • Oxford BioMedica, Sanofi Announce Interim Results For Wet AMD Drug

    (http://www.MacularDegenerations.com) Oxford BioMedica, the Oxford, England-based biopharmaceutical company developing gene-based medicines and therapeutic vaccines, and its partner Sanofi, the Paris, France-based diversified healthcare company, have announced a new development regarding testing of their age-related macular degeneration drug (AMD). In an 8 August press release, Oxford and Sanofi announced an encouraging interim assessment of their RetinoStat […]

  • Apeliotus Vision Science’s Readying AdaptDx Product For Roll Out

    (www.MacularDegenerations.com) Apeliotus Vision Science is pursuing series A financing worth $4 million in order to advance a product designed to identify the beginning phases of age-related macular degeneration (AMD), reported MEDCITY on August 7. Apeliotus Vision Science Chief Executive Officer John Edwards said in the article focusing on the development that the company is on […]

121212121